Home > PS Ratio > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
PS (Price/Sales) Ratio

The Current P/S Ratio of SYNCOM FORMULATIONS (INDIA) is 6.21.

Share Price ₹21.8Dec 12,2024
Market Cap ₹2,045.4 Cr
Sales-TTM₹329.3 CrTTM-Consolidated Results
Price/Sales6.21xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SYNCOM FORMULATIONS (INDIA)

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SYNCOM FORMULATIONS (INDIA) is calculated as :

Current Market Cap [ ₹2,045.4 Cr] as on Dec 12,2024

(/) Sales [ ₹329.3 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 6.21x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '6.21 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SYNCOM FORMULATIONS (INDIA) !

The chart below summarizes the trend in P/S Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.

Historical PS (Price/Sales) ratio chart of SYNCOM FORMULATIONS (INDIA)


PS Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)

- SYNCOM FORMULATIONS (INDIA) 's latest p/e ratio is 6.21x.

- SYNCOM FORMULATIONS (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2016 averaged 2.48x.

- SYNCOM FORMULATIONS (INDIA) 's operated at median p/e ratio of 2.47x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/e ratio peaked in Mar2022 at 4.17x.

- SYNCOM FORMULATIONS (INDIA) 's p/e ratio hit its five-year low in Mar2017 of 0.83x.


How does SYNCOM FORMULATIONS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SYNCOM FORMULATIONS (INDIA) 329.36.212,045.4
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.61432,948.0
CIPLA LTD26,512.04.41116,809.0
DR REDDYS LABORATORIES LTD30,084.93.46103,963.0
ZYDUS LIFESCIENCES LTD21,483.54.5798,173.2
DIVIS LABORATORIES LTD8,614.018.33157,873.0
MANKIND PHARMA LTD11,018.09.64106,198.0
TORRENT PHARMACEUTICALS LTD11,225.010.04112,643.0
LUPIN LTD21,431.34.5196,581.6
AUROBINDO PHARMA LTD30,295.02.3370,576.1
ABBOTT INDIA LTD6,066.110.0661,032.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.33x
Max industry PS 18.33x
Median industry PS 6.21x
Average industry PS 7.47x



You may also like the below Video Courses